Exome and Genome Sequencing and Parallels in Radiology: Searching for Patient-Centered Management of Incidental and Secondary Findings

被引:5
|
作者
Kang, Stella K. [1 ,2 ]
Spector-Bagdady, Kayte [3 ]
Caplan, Arthur L. [4 ]
Braithwaite, R. Scott [2 ,5 ]
机构
[1] NYU, Sch Med, Dept Radiol, New York, NY USA
[2] NYU, Sch Med, Dept Populat Hlth, New York, NY USA
[3] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI USA
[4] NYU, Dept Populat Hlth, Div Med Eth, Sch Med, New York, NY USA
[5] NYU, Sch Med, Dept Med, New York, NY USA
关键词
Incidental finding; genome sequencing; patient-centered care; WHITE PAPER; COMMITTEE II; PELVIC CT; AUTONOMY; RETURN; MRI;
D O I
10.1016/j.jacr.2016.06.050
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Incidental and secondary findings have become an important by-product of diagnostic testing, and their ramifications affect clinical care, research, and policy. Given parallels in the reporting and management of such findings on diagnostic imaging, radiologists may draw from ongoing discussions in medical genetics to rethink more patient-centered approaches to analogous clinical, ethical, and medicolegal dilemmas. Low-risk incidental findings in particular may be drivers of unnecessary testing, invasive procedures, and overtreatment, with associated financial, psychological, and clinical consequences. As radiologists act in patients' best interests by strengthening standardized guidelines on how each finding merits further diagnostic testing or treatment, perhaps the greatest challenge for producing such guidelines is for low-risk incidental findings, for which adverse consequences are unlikely but associated with substantial uncertainty because of the lack of strong evidence on which to base the recommendations. More uniform recommendations for managing low-risk radiologic incidental findings should therefore aim to provide reasonable options that apply across a spectrum of patient preferences. These will require evaluation through research and will ultimately influence the quality of care. Specific areas for exploration may include (1) better gauging of patient attitudes and preferences regarding low-risk incidental findings, (2) using patient preferences to inform more uniform recommendations for low-risk findings that apply across a spectrum of preferences and help guide shared decision making, and (3) when patients endorse a strong preference not to discover low-risk incidental findings, how it might be possible for professional standards to curtail their generation in specific circumstances.
引用
收藏
页码:1467 / 1472
页数:6
相关论文
共 43 条
  • [31] Taking a proactive role in patient management of important incidental imaging findings: How can we increase the ‘value’ of diagnostic radiology service and improve quality of patient care?
    Daichi Hayashi
    Ali Guermazi
    Japanese Journal of Radiology, 2018, 36 : 579 - 580
  • [32] Clinical genome sequencing and population preferences for information about 'incidental' findings D From medically actionable genes (MAGs) to patient actionable genes (PAGs)
    Ploug, Thomas
    Holm, Soren
    PLOS ONE, 2017, 12 (07):
  • [33] SEE-diabetes, a patient-centered diabetes self-management education and support for older adults: Findings and information needs from providers' perspectives
    Narindrarangkura, Ploypun
    Boren, Suzanne A.
    Khan, Uzma
    Day, Margaret
    Simoes, Eduardo J.
    Kim, Min Soon
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (09)
  • [34] SEE-Diabetes, a patient-centered diabetes self-management education and support for older adults: Findings and information needs from patients' perspectives
    Narindrarangkura, Ploypun
    Boren, Suzanne A.
    Khan, Uzma
    Day, Margaret
    Simoes, Eduardo J.
    Kim, Min Soon
    PRIMARY CARE DIABETES, 2022, 16 (03) : 395 - 403
  • [35] ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
    Miller, David T.
    Lee, Kristy
    Abul-Husn, Noura S.
    Amendola, Laura M.
    Brothers, Kyle
    Chung, Wendy K.
    Gollob, Michael H.
    Gordon, Adam S.
    Harrison, Steven M.
    Hershberger, Ray E.
    Klein, Teri E.
    Richards, C. Sue
    Stewart, Douglas R.
    Martin, C. L.
    GENETICS IN MEDICINE, 2023, 25 (08)
  • [36] ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
    Miller, David T.
    Lee, Kristy
    Chung, Wendy K.
    Gordon, Adam S.
    Herman, Gail E.
    Klein, Teri E.
    Stewart, Douglas R.
    Amendola, Laura M.
    Adelman, Kathy
    Bale, Sherri J.
    Gollob, Michael H.
    Harrison, Steven M.
    Hershberger, Ray E.
    McKelvey, Kent
    Richards, C. Sue
    Vlangos, Christopher N.
    Watson, Michael S.
    Martin, Christa Lese
    GENETICS IN MEDICINE, 2021, 23 (08) : 1381 - 1390
  • [37] ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
    Miller, David T.
    Lee, Kristy
    Abul-Husn, Noura S.
    Amendla, Laura M.
    Brothers, Kyle
    Chung, Wendy K.
    Gollob, Michael H.
    Gordon, Adam S.
    Harrison, Steven M.
    Hershberger, Ray E.
    Klein, Teri E.
    Richards, Carolyn Sue
    Stewart, Douglas R.
    Martin, Christa Lese
    GENETICS IN MEDICINE, 2022, 24 (07) : 1407 - 1414
  • [38] Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics
    Kalia, Sarah S.
    Adelman, Kathy
    Bale, Sherri J.
    Chung, Wendy K.
    Eng, Christine
    Evans, James P.
    Herman, Gail E.
    Hufnagel, Sophia B.
    Klein, Teri E.
    Korf, Bruce R.
    McKelvey, Kent D.
    Ormond, Kelly E.
    Richards, C. Sue
    Vlangos, Christopher N.
    Watson, Michael
    Martin, Christa L.
    Miller, David T.
    GENETICS IN MEDICINE, 2017, 19 (02) : 249 - 255
  • [39] Patient-centered home-based management of heart failure, findings from a randomized clinical trial evaluating effects on knowledge, self-care and quality of life
    Melin, M.
    Hagglund, E.
    Frie, F.
    Lynga, P.
    Ullman, B.
    Persson, H.
    Hagerman, I.
    EUROPEAN HEART JOURNAL, 2014, 35 : 838 - 838
  • [40] Use of targeted sequencing of cancer genome (cancer panel) to develop patient-centered therapeutic target based on molecular alternations: A pilot prospective study for 25 patients with refractory and metastatic cancer and treatment response
    Kwon, Chae Hwa
    Seol, Young Mi
    Kim, Young Keum
    Choi, Yuri
    Won, Yeo Jin
    Park, Do Youn
    CANCER RESEARCH, 2017, 77